{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:44:27Z","timestamp":1778337867931,"version":"3.51.4"},"reference-count":41,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"The Netherlands Cancer Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2024,10,7]]},"DOI":"10.1021\/acs.molpharmaceut.4c00542","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T19:50:47Z","timestamp":1727121047000},"page":"5159-5170","source":"Crossref","is-referenced-by-count":3,"title":["Brain Exposure to the Macrocyclic ALK Inhibitor Zotizalkib is Restricted by ABCB1, and Its Plasma Disposition is Affected by Mouse Carboxylesterase 1c"],"prefix":"10.1021","volume":"21","author":[{"given":"Jamie","family":"Rijmers","sequence":"first","affiliation":[{"name":"Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf W.","family":"Sparidans","sequence":"additional","affiliation":[{"name":"Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht 3584 CS, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Acda","sequence":"additional","affiliation":[{"name":"Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8507-0280","authenticated-orcid":true,"given":"Nancy H. C.","family":"Loos","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouela","family":"Epeslidou","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vi\u00ebt","family":"Bui","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C.","family":"Lebre","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"Tibben","sequence":"additional","affiliation":[{"name":"Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos H.","family":"Beijnen","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"},{"name":"Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht 3584 CS, The Netherlands"},{"name":"Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4215-8602","authenticated-orcid":true,"given":"Alfred H.","family":"Schinkel","sequence":"additional","affiliation":[{"name":"Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13397"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-017-0526-1"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-22-631"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers9090118"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081074"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13397"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14194765"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-21-0221"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0241"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007478"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-2906"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-022-00919-5"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2027187"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.145"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32461"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.011.10466"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19325-x"},{"key":"ref18\/cit18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-7647-4","volume-title":"Drug Transporters in Drug Disposition, Effects and Toxicity","author":"Liu X.","year":"2019"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2016.1168804"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-006-0042-9"},{"key":"ref21\/cit21","first-page":"241","volume":"4","author":"Nakanishi T.","year":"2007","journal-title":"Cancer Genomics Proteomics"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-010510-100556"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00430.x"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41552-8"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.4149\/gpb_2020043"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112686"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2.2.171"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.12.007"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2018.05.005"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.089680"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.048397"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-017-0437-z"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28475"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.09.003"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31582"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103537"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.843829"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0596"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.09.020"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1200\/jco.24.00581"},{"key":"ref41\/cit41","volume-title":"A Study of NVL-655 in Patients with Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)","author":"ClinicalTrials.gov","year":"2024"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.4c00542","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.4c00542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T08:10:29Z","timestamp":1728288629000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.4c00542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,7]]}},"alternative-id":["10.1021\/acs.molpharmaceut.4c00542"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00542","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}